These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21888900)

  • 21. Is prevalence of PBC underestimated in patients with systemic sclerosis?
    Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
    Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticentromere antibody in primary biliary cirrhosis.
    Bernstein RM; Callender ME; Neuberger JM; Hughes GR; Williams R
    Ann Rheum Dis; 1982 Dec; 41(6):612-4. PubMed ID: 7149799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of rheumatoid arthritis associated with progressive systemic sclerosis and primary biliary cirrhosis in the presence of various autoantibodies].
    Maekawa S; Yano E; Shintani S
    Ryumachi; 1992 Oct; 32(5):515-21. PubMed ID: 1440089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis.
    Liberal R; Grant CR; Sakkas L; Bizzaro N; Bogdanos DP
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):572-85. PubMed ID: 23876351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies against cytoskeletal proteins in rheumatoid arthritis.
    Shrivastav M; Mittal B; Aggarwal A; Misra R
    Clin Rheumatol; 2002 Nov; 21(6):505-10. PubMed ID: 12447636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoepitope mapping of the centrosome autoantigen PCM-1 using scleroderma sera with anticentrosome autoantibodies.
    Bao L; Zimmer WE; Balczon R
    Autoimmunity; 1995; 22(4):219-28. PubMed ID: 8781714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver autoantibodies in patients with scleroderma.
    Skare TL; Nisihara RM; Haider O; Azevedo PM; Utiyama SR
    Clin Rheumatol; 2011 Jan; 30(1):129-32. PubMed ID: 20931345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin.
    Rodriguez-Sanchez JL; Gelpi C; Juarez C; Hardin JA
    J Immunol; 1987 Oct; 139(8):2579-84. PubMed ID: 3309055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new substrate for the detection of antimitochondrial antibodies in human serum].
    Martínez S; Berríos S; Morales M; Cuchacovic M; Brahm J; Fernández-Donoso R
    Rev Med Chil; 1994 Aug; 122(8):889-99. PubMed ID: 7761719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
    Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
    Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
    Schachna L; Wigley FM; Morris S; Gelber AC; Rosen A; Casciola-Rosen L
    Arthritis Rheum; 2002 Jul; 46(7):1873-84. PubMed ID: 12124872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serology in patients with scleroderma].
    Ullman S; Halberg P; Høier-Madsen M; Kang L; Konstantinov K; Pedersen K; Rasmussen E; Wiik A
    Ugeskr Laeger; 1993 Feb; 155(7):472-6. PubMed ID: 8465453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CENP-B autoantigen is a conserved protein from humans to higher plants: identification of the aminoterminal domain in Phaseolus vulgaris.
    Barbosa-Cisneros O; Fraire-Velázquez S; Moreno J; Herrera-Esparza R
    Rev Rhum Engl Ed; 1997 Jun; 64(6):368-74. PubMed ID: 9513608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of anti-Ku autoantibodies--a serologic marker of overlap syndrome?
    Mimori T
    Intern Med; 2002 Dec; 41(12):1096-8. PubMed ID: 12521194
    [No Abstract]   [Full Text] [Related]  

  • 39. Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases.
    Ruffatti A; Calligaro A; Ferri C; Bombardieri S; Gambari PF; Todesco S
    J Clin Lab Immunol; 1985 Apr; 16(4):227-9. PubMed ID: 3874966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scl-86, a marker antigen for diffuse scleroderma.
    van Venrooij WJ; Stapel SO; Houben H; Habets WJ; Kallenberg CG; Penner E; van de Putte LB
    J Clin Invest; 1985 Mar; 75(3):1053-60. PubMed ID: 3980727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.